A Proposal for Oversight of Gene Editing in Human Embryos Using CRISPR-Cas9 Technology

IF 0.3 4区医学 Q3 LAW

Journal of Legal Medicine Pub Date : 2020-08-28 DOI:10.1080/01947648.2020.1833647

Jay Xiong, Ronny Yip, Weldon Havins

引用次数: 0

Abstract

The increasing growth of genomic technology has created the potential for cures of previously untreatable diseases. CRISPR-Cas9 technology is a new gene editing tool discovered to have the ability ...

查看原文本刊更多论文

关于使用CRISPR-Cas9技术监督人类胚胎基因编辑的建议

基因组技术的不断发展为治愈以前无法治愈的疾病创造了潜力。CRISPR-Cas9技术是一种新的基因编辑工具，被发现具有…

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Legal Medicine Multiple-

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： The Journal of Legal Medicine is the official quarterly publication of the American College of Legal Medicine (ACLM). Incorporated in 1960, the ACLM has among its objectives the fostering and encouragement of research and study in the field of legal medicine. The Journal of Legal Medicine is internationally circulated and includes articles and commentaries on topics of interest in legal medicine, health law and policy, professional liability, hospital law, food and drug law, medical legal research and education, the history of legal medicine, and a broad range of other related topics. Book review essays, featuring leading contributions to the field, are included in each issue.